Mayank Mamtani Analyst PerformanceAnalyst at B. RileyMayank Mamtani is a stock analyst at B. Riley, covering 37 publicly traded companies across a range of sectors. Over the past year, Mayank Mamtani has issued 11 stock ratings, including strong buy, buy, and hold recommendations. While full access to Mayank Mamtani's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mayank Mamtani's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Ratings, Coverage, and Performance StatisticsAnalyst RatingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings158 Last 6 YearsBuy Recommendations90.00% 135 Buy RatingsCompanies Covered37 Unique Companies Ratings Distribution150RatingsDistribution of strong buy, buy, hold, and sell ratings by Mayank Mamtani.RatingPercentageCount Strong Buy0.7%1 ratings Buy89.3%134 ratings Hold10.0%15 ratings Sell0.0%0 ratingsOut of 150 total stock ratings issued by Mayank Mamtani at B. Riley, the majority (89.3%) have been Buy recommendations, followed by 10.0% Hold and 0.7% Strong Buy.Best & Worst CallsBest Call0000.0%ALNAMar 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%NVAXApr 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ94.6% of companies on NASDAQ35 companiesNYSEAMERICAN2.7% of companies on NYSEAMERICAN1 companyOTCMKTS2.7% of companies on OTCMKTS1 companyMayank Mamtani, an analyst at B. Riley, currently covers 37 companies listed on NASDAQ, NYSEAMERICAN and OTCMKTS, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical37 companies100.0%Mayank Mamtani of B. Riley specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE17 companies45.9%PHARMACEUTICAL PREPARATIONS8 companies21.6%MED - DRUGS7 companies18.9%BIOTECHNOLOGY3 companies8.1%MED PRODUCTS1 company2.7%BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC1 company2.7% Mayank Mamtani's Ratings History at B. Riley Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Time Frame Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsACTUActuate Therapeutics8/26/2025Initiated Coverage$7.98$20.00Buy$0.0000.00% ROIACTUActuate Therapeutics8/25/2025Initiated Coverage$8.19$20.00Buy$0.0000.00% ROIALTAltimmune8/13/2025Lower Price Target$3.62$18.00Buy$0.0000.00% ROIMNOVMediciNova6/16/2025Upgrade$1.31$5.00Strong-Buy$0.0000.00% ROIMGNXMacroGenics5/20/2025Lower Price Target$1.57$3.00Neutral$0.0000.00% ROIHROWHarrow4/1/2025Lower Price Target$25.23$65.00Buy$0.0000.00% ROIVXRTVaxart3/27/2025Lower Price Target$0.45$2.00Buy$0.0000.00% ROITRVITrevi Therapeutics3/19/2025Reiterated Rating$6.69$20.00Buy$0.0000.00% ROILCTXLineage Cell Therapeutics3/14/2025Lower Price Target$0.52$3.00Buy$0.0000.00% ROIDNLIDenali Therapeutics3/5/2025Reiterated Rating$16.06$35.00Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals2/14/2025Reiterated Rating$19.75$38.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
